AOYAGI Yutaka

J-GLOBAL         Last updated: Dec 8, 2010 at 00:00
 
Avatar
Name
AOYAGI Yutaka
Affiliation
Niigata University
Section
Graduate School of Medical and Dental Sciences, Course for Molecular and Cellular Medicine
Job title
Professor
Degree
(BLANK)

Research Areas

 
 

Education

 
 
 - 
1979
Graduate School, Division of Medicine, Niigata University
 
 
 - 
1973
Faculty of Medicine, Niigata University
 

Misc

 
Comparative chemical structures of human α-fetoprotein form fetal serum and from ascites fluid of a patient with hepatoma.
Aoyagi Y, Ikenaka T, and Ichida F.
Cancer Research   37 3663-3667   1977
Copper(II)-binding ability of human α-fetoprotein
Aoyagi Y, Ikenaka T, and Ichida F.
Cancer Research   38 3483-3486   1978
α-Fetoprotein as a carrier protein in plasma and its bilirubin-binding ability
Aoyagi Y, Ikenaka T. and Ichida F.
Cancer Research   39 3571-3574   1979
Kojima N, Isemura M, Yosizawa Z, Ono T, Shinada S, Soga K, Aoyagi Y. and Ichida F.
Tohoku J. exp. Med.   135(4) 403-412   1981
Inhibitory effect of alpha-fetoprotein on protein synthesis in a reticulocyte lysate cell-free system.
Aoyagi Y, Takahashi T, Odani S, Ogata K, Ono T. and Ichida F.
J. Biol. Chem.   257 . 9566-9569   1982

Books etc

 
Copper(II)-binding ability of human alpha-fetoprotein.
Scand. J. Immunol.   1978   
Bilirubin-binding ability of human alpha-fetoprotein
Carcino-Embryonic Proteins   1979   
Measurement of differential affinity of alpha-fetoprotein with lectins in diagnosis of hepatocellular carcinoma.In Ten years of the Japan Medical Research Foundation
Japan Medical Foundation, University of Tokyo Press   1983   
Immunoelectron microscopic demonstration of fibronectin in normal and fibrotic livers.
Pathology of Hepatic Fibrosis.   1985   
Gastric mucosal lesions in patients with chronic liver diseases.
Gastrointestinal Functions: Regulation and Disturbance   1994   

Research Grants & Projects

 
Clinical and biochemical studies on alpha-fetoprotein
diagnosis and treatment for hepatic encephalopathy
alteration of serum glycoprotein in cancer patients